Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10622910 | 0.84 | CYP1A2 (0.44) | ALDH1A1HTTCA12CA1CA2 | |
| SCHEMBL5186624 | 0.84 | ALDH1A1 (0.54) | ALDH1A1HPGDHTTATMCA12 | |
| SCHEMBL27907766 | 0.83 | CA12 (0.58) | ALDH1A1HPGDHTTATMCA12 | |
| SCHEMBL30389755 | 0.83 | CA12 (0.58) | ALDH1A1HPGDHTTATMCA12 | |
| SCHEMBL7701905 | 0.83 | ALDH1A1 (0.53) | ALDH1A1HPGDHTTATMMAPT | |
| SCHEMBL2991009 | 0.83 | CA12 (0.58) | ALDH1A1HPGDHTTATMCA12 | |
| SCHEMBL8680479 | 0.81 | HSD17B3 (0.51) | ALDH1A1HTTATMMAPTL3MBTL1 | |
| SCHEMBL14357333 | 0.80 | HPGD (0.50) | ALDH1A1HPGDHTTATMMAPT | |
| SCHEMBL27564987 | 0.80 | ALDH1A1 (0.54) | ALDH1A1HPGDHTTATMCA12 | |
| SCHEMBL28732226 | 0.80 | HSP90AB1 (0.69) | ALDH1A1HPGDHTTATMCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8536157-B2 | Non-steroidal compounds | THE UNIVERSITY OF MELBOURNE (AU) | 2013-09-17 | — | — | US | disclosed |
| US-20120046255-A1 | NON-STEROIDAL COMPOUNDS | THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) | 2012-02-23 | — | — | US | disclosed |
| CN-102119147-A | Oxime ether derivative and bactericide for agricultural and horticultural use | NIPPON SODA CO | 2011-07-06 | — | — | CN | disclosed |
| EP-0609885-B1 | Acridinium compounds and conjugates thereof | MOCHIDA PHARM CO LTD (JP) | 2003-04-16 | — | — | EP | disclosed |
| US-5594112-A | CHEMILUMINESCENCE LABEL | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1997-01-14 | — | — | US | disclosed |
| US-5438139-A | Chemiluminescent; useful as immunolochemical, DNA probe and receptor bininding assays | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1995-08-01 | — | — | US | disclosed |
| EP-0609885-A1 | Acridinium compounds and conjugates thereof | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1994-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046255-A1 | NON-STEROIDAL COMPOUNDS | PTGES2, PTGES, PTGES3 | ALDH1A1 2237/4885HPGD 158/4885HTT 3412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.